Abstract
Ectopic production of the immunoreactive β‐subunit of human chorionic gonadotropin (IR‐hCGβ) by gynecologic malignancies has been well recognized, but IR‐hCGβ has not yet been established as a clinically useful tumor marker, except for germ cell tumors. We measured the concentrations of IR‐hCGβ‐related molecules, intact hCG, free hCGβ, and β‐CF, in the sera and urine of patients with various gynecologic cancers (cervical, endometrial, and ovarian cancers) to assess their clinical usefulness as a tumor marker in comparison with serum tumor markers such as CEA, SCC, CA125, and CA19‐9. The highest incidence of IR‐hCGβ was obtained in tbe assay for β‐CF in the urine, with positive rates of 47.7% (94 of 197) for cervical, 37.8% (14 of 37) for endometrial, and 84.4% (38 of 45) for ovarian cancers with a cut‐off value of 0.2 ng/mg of creatinine. In cervical cancer, there was no significant correlation between the concentrations of urinary β‐CF and serum SCC, and 57.9% (114 of 197) of the patients were detected by the combination assay of these tumor markers. Serial determination in 22 cervical cancer patients with elevated urinary β‐CF level prior to therapy showed that its level decreased after successful treatment, but 4 of 5 patients with persistent or recurrent disease had elevated levels of urinary β‐CF. All of the ovarian cancer patients examined were detected by the combination assay of urinary β‐CF and serum CA125. The levels of urinary β‐CF showed little correlation with those of the serum tumor markers, indicating the usefulness of the combination assay of urinary β‐CF with serum tumor markers for detecting cervical and ovarian cancers.
Keywords: Tumor marker, Chorionic gonadotropin, Ectopic production, Gynecologic cancer, Urinary protein
Full Text
The Full Text of this article is available as a PDF (392.6 KB).
REFERENCES
- 1. ) Hussa , R. O.Human chorionic gonadotropin, a clinical marker: review of its biosynthesis . Ligand Rev. , 3 ( Suppl. 2 ), 1 – 44 ( 1981. ). [Google Scholar]
- 2. ) Braunstein , G. D. , Vaitukaitis , J. L. , Carbone , P. P. and Ross , G. T.Ectopic production of human chorionic gonadotropin by neoplasms . Ann. Intern. Med. , 78 , 39 – 45 ( 1973. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Blackman , M. R. , Weintraub , B. D. , Rosen , S. W. , Kourides , I. A. , Steinwasher , K. and Gail , M. H.Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment . J. Natl. Cancer Invest. , 65 , 81 – 93 ( 1980. ). [PubMed] [Google Scholar]
- 4. ) Rutanen , E. M. and Seppala , M.The hCG‐subunit radioimmunoassay in non‐trophoblastic gynecologic tumors . Cancer , 41 , 692 – 696 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Donaldson , E. S. , van Nagell , J. R. , Pursell , S. , Gay , E. C. , Meeker , W. R. , Kashmiri , R. and van de Vooder , J.Multiple biochemical markers in patients with gynecologic malignancies . Cancer , 45 , 948 – 953 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Papapetrou , P. D. , Sakarelou , N. P. , Braouzi , H. and Fessas , P. H.Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: the value of measurement of immunoreactive hCG in the urine as a screening procedure . Cancer , 45 , 2583 – 2592 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Papapetrou , P. D. and Nicopoulou , S. C.The origin of a human chorionic gonadotropin β‐subunit‐core fragment excreted in the urine of patients with cancer . Acta Endocrinol. , 112 , 415 – 422 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Iles , R. K. and Chard , T.Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential . J. Urol. , 145 , 453 – 458 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Nishimura , R. , Kitajima , T. , Hasegawa , K. , Takeuchi , K. and Mochizuki , M.Molecular forms of human chorionic gonadotropin in choriocarcinoma serum and urine . Jpn. J. Cancer Res. , 80 , 968 – 974 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Amr , S. , Rosa , C. , Wehmann , R. , Birken , S. and Nisula , B.Unusual molecular forms of hCG in gestational trophoblastic neoplasia . Ann. Endocrinol. , 45 , 321 – 326 ( 1984. ). [PubMed] [Google Scholar]
- 11. ) O'Connor , J. F. , Schlatterer , J. P. , Birken , S. , Krichevsky , A. , Armstrong , E. G. , McMahon , D. and Canfield , R. E.Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its β‐subunit, and β core fragment in the urine: application to malignancies . Cancer Res. , 48 , 1362 – 1366 ( 1988. ). [PubMed] [Google Scholar]
- 12. ) Cole , L. A. , Wang , Y. , Elliot , M. , Latif , M. , Chambers , J. T. , Chambers , S. K. and Schwartz , P. E.Urinary human chorionic gonadotropin free β‐subunit and β‐core fragment: a new marker of gynecological cancers . Cancer Res. , 48 , 1356 – 1360 ( 1988. ). [PubMed] [Google Scholar]
- 13. ) Yoshimura , M. , Nishimura , R. , Murotani , A. , Miyamoto , Y. , Nakagawa , T. , Hasegawa , K. , Koizumi , T. , Shii , K. , Baba , S. and Tsubota , N.Assessment of urinary β‐core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer . Cancer , 73 , 2745 – 2752 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Kato , H. , Morioka , H. , Tsutsui , H. , Aramaki , S. and Torigoe , T.Value of tumor antigen (TA‐4) of squamous cell carcinoma in predicting the extent of cervical cancer . Cancer , 50 , 1294 – 1296 ( 1982. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Bast , R. C. , Klug , T. L. , St. John , E. , Jenison , E. , Niloff , J. M. , Lazarus , H. , Berkowitz , R. S. , Leavitt , T. , Griffiths , C. T. , Parker , L. , Zurawski , V. R. and Knapp , R. C.A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer . N. Engl. J. Med. , 309 , 883 – 887 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Birken , S. , Armstrong , E. G. , Gawinowicz‐Kolks , M. A. , Cole , L. A. , Agost , G. M. , Krichevsky , A. , Vaitukaitis , J. L. and Canfield , R. E.Structure of the human chorionic gonadotropin β‐subunit fragment from pregnancy urine . Endocrinology , 123 , 572 – 583 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Endo , T. , Nishimura , R. , Saito , S. , Kanazawa , K. , Nomura , K. , Katsuno , M. , Shii , K. , Mukhopadhyay , K. , Baba , S. and Kobata , A.Carbohydrate structures of β‐core fragment of human chorionic gonadotropin isolated from a pregnant individual . Endocrinology , 130 , 2052 – 2058 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Nishimura , R. , Koizumi , T. , Morisue , K. , Yamanaka , N. , Lalwani , R. , Yoshimura , M. , Nakagawa , T. , Shii , K. , Hasegawa , K. and Baba , S.Expression and secretion of the β‐subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro . Cancer Res. , 55 , 1479 – 1484 ( 1995. ). [PubMed] [Google Scholar]